Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (26)

2023

  1. Cognitive Deficits in Aging Related to Changes in Basal Forebrain Neuronal Activity

    Cells, Vol. 12, Núm. 11

  2. The Role of Insulin-like Growth Factor I in Mechanisms of Resilience and Vulnerability to Sporadic Alzheimer’s Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 22

  3. The neurobiology of insulin-like growth factor I: From neuroprotection to modulation of brain states

    Molecular Psychiatry, Vol. 28, Núm. 8, pp. 3220-3230

2022

  1. Insulin-like growth factor I mitigates post-traumatic stress by inhibiting AMP-kinase in orexin neurons

    Molecular Psychiatry, Vol. 27, Núm. 4, pp. 2182-2196

  2. Insulin-like growth factor I sensitization rejuvenates sleep patterns in old mice

    GeroScience, Vol. 44, Núm. 4, pp. 2243-2257

  3. Response Facilitation Induced by Insulin-like Growth Factor-I in the Primary Somatosensory Cortex of Mice Was Reduced in Aging

    Cells, Vol. 11, Núm. 4

2021

  1. Astrocytic IGF-IRs induce adenosine-mediated inhibitory downregulation and improve sensory discrimination

    Journal of Neuroscience, Vol. 41, Núm. 22, pp. 4768-4781

  2. Cholinergic and cortical activity is recovered by insulin-like growth factor I in aging mice brains

    Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol. 17, pp. e054655

  3. Loss of sensitivity to insulin-like growth factor I in orexin neurons is associated to perturbed sleep patterns during aging

    Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol. 17, pp. e054682

  4. Reduced Insulin-Like Growth Factor-I Effects in the Basal Forebrain of Aging Mouse

    Frontiers in Aging Neuroscience, Vol. 13

2020

  1. Insulin-like growth factor I modulates sleep through hypothalamic orexin neurons

    FASEB Journal, Vol. 34, Núm. 12, pp. 15975-15990

2019

  1. Serum Insulin-like growth factor i deficiency associates to Alzheimer's disease Co-morbidities

    Journal of Alzheimer's Disease, Vol. 69, Núm. 4, pp. 979-987

2016

  1. Class I PI3-kinase or Akt inhibition do not impair axonal polarization, but slow down axonal elongation

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1863, Núm. 11, pp. 2574-2583

2013

  1. Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice

    Translational Psychiatry, Vol. 3

2010

  1. Neuronal Activity Drives Localized Blood-Brain-Barrier Transport of Serum Insulin-like Growth Factor-I into the CNS

    Neuron, Vol. 67, Núm. 5, pp. 834-846

2009

  1. Independent alterations in the central and peripheral somatosensory pathways in rat diabetic neuropathy

    Neuroscience, Vol. 160, Núm. 2, pp. 402-411

2007

  1. Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects

    Molecular Psychiatry, Vol. 12, Núm. 12, pp. 1118-1128

  2. Insulin and insulin-like growth factor I signalling in neurons

    Frontiers in Bioscience, Vol. 12, Núm. 9, pp. 3194-3202

2003

  1. Brain repair and neuroprotection by serum insulin-like growth factor I

    Molecular Neurobiology, Vol. 27, Núm. 2, pp. 153-162

  2. Insulin-like growth factor I modifies electrophysiological properties of rat brain stem neurons

    Journal of Neurophysiology, Vol. 89, Núm. 6, pp. 3008-3017